Sanford Starts Blood Plasma Therapy for COVID Patients
April 21, 2020
April 21, 2020
SIOUX FALLS, South Dakota, April 21 -- Sanford Health issued the following news:
A critically ill patient has received a transfusion of plasma from a recovered COVID-19 patient, the first use of the therapy in the Sanford Health system.
The treatment is part of a national clinical trial to test the effect of blood plasma in treating COVID-19. The use of plasma under this program is for hospitalized patients with severe COVID-19, or those at high risk of progression to l . . .
A critically ill patient has received a transfusion of plasma from a recovered COVID-19 patient, the first use of the therapy in the Sanford Health system.
The treatment is part of a national clinical trial to test the effect of blood plasma in treating COVID-19. The use of plasma under this program is for hospitalized patients with severe COVID-19, or those at high risk of progression to l . . .